864072-82-2

Upstream product

• 110-85-0 piperazine 
• 66684-58-0 3,4,5-trifluoronitrobenzene 

Downstream Products

• 1188400-79-4 [4-(2,6-difluoro-4-nitrophenyl)piperazin-1-yl]phosphonic dichloride 
• 154590-82-6 tert-butyl 4-(2,6-difluoro-4-nitrophenyl)piperazine-1-carboxylate 
• 1188400-81-8 3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenylamine 
• 1188400-80-7 1-(2,6-difluoro-4-nitro-phenyl)-4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazine 
• 1188400-77-2 (S)-5-aminomethyl-3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-oxazolidin-2-one 
• 1188400-83-0 (R)-3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-5-hydroxymethyl-oxazolidin-2-one 
• 1188400-82-9 {3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-carbamic acid benzyl ester 
• 1188400-85-2 (R)-5-azidomethyl-3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-oxazolidin-2-one 
• 1188400-71-6 (R)-3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-5-[1,2,3]triazol-1-ylmethyl-oxazolidin-2-one 
• 1188400-84-1 (R)-methanesulfonic acid 3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-2-oxo-oxazolidin-5-ylmethyl ester 
• 1188400-54-5 (S)-N-(3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide 
• 1188400-66-9 (S)-(3-{3,5-difluoro-4-[4-(2-oxo-2λ5-[1,3,2]dioxaphosphinan-2-yl)-piperazin-1-yl]-phenyl}-2-oxo-oxazolidin-5-ylmethyl)-carbamic acid methyl ester 

Relevant academic research and scientific papers

PYRAZOLOPYRIMIDONE AND PYRAZOLOPYRIDONE INHIBITORS OF TANKYRASE

There are provided compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein Q, R1 and R2 are as defined herein. The compounds of formula I are useful in the treatment of cancer.

NOVEL ANTIMICROBIALS

The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the

NOVEL ANTIMICROBIALS

The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The

NOVEL TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

The present invention relates to novel triazole compounds of formula (I), where all symbols are as defined in the detailed description; their pharmaceutically acceptable salts their stereosiomers thereof, their prodrugs, their rotamers, their pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.